{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:57:39Z","timestamp":1773129459792,"version":"3.50.1"},"reference-count":35,"publisher":"LLC Obyedinennaya Redaktsiya","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ter. arkh."],"published-print":{"date-parts":[[2016]]},"DOI":"10.17116\/terarkh201688762-71","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T11:15:57Z","timestamp":1469013357000},"page":"62","source":"Crossref","is-referenced-by-count":6,"title":["Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia"],"prefix":"10.26442","volume":"88","author":[{"given":"E. S.","family":"Nesterova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Kravchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya. K.","family":"Mangasarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Baryakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Misyurina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. I.","family":"Vorobyev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. V.","family":"Plastinina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. G.","family":"Chernova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Kovrigina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. N.","family":"Obukhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Klyasova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Shevelev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. E.","family":"Kostina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. G.","family":"Gemdzhian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. V.","family":"Gaponova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. I.","family":"Vorobyev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","reference":[{"key":"key-10.17116\/terarkh201688762-71-1","unstructured":"Davydov M, Axel E. Statistics of malignant neoplasms in Russia and CIS countries in 2009. Moscow, Bulletin of N.N. Blokhin RONC Russian Academy of medical Sciences. 2011;22(1). (In Russ.)"},{"key":"key-10.17116\/terarkh201688762-71-2","doi-asserted-by":"crossref","unstructured":"Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Gr\u00fcnhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, D\u00fcrk H,Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Bendamustine plus rituximab versus CHOP plus rituximab as fi rst-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet. 2013;381(9873):1203-1210.","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"key-10.17116\/terarkh201688762-71-3","doi-asserted-by":"crossref","unstructured":"Ladetto M, De Marco F, Benedetti F, Vitolo U, Patti C, Rambaldi A, Pulsoni A, Musso M, Liberati AM, Olivieri A, Gallamini A, Pogliani E, Rota Scalabrini D,Callea V, Di Raimondo F, Pavone V, Tucci A, Cortelazzo S, Levis A, Boccadoro M, Majolino I, Pileri A, Gianni AM, Passera R, Corradini P, Tarella C; Gruppo Italiano Trapianto di Midollo Osseo (GITMO); Intergruppo Italiano Linfomi (IIL). Prospective, multicenter randomized GITMO\/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage. Blood. 2008;111:4004-4013.","DOI":"10.1182\/blood-2007-10-116749"},{"key":"key-10.17116\/terarkh201688762-71-4","doi-asserted-by":"crossref","unstructured":"Barr P. M., Lazarus H. M. Follicular non-Hodgkin lymphoma: long-term results of stem-cell transplantation. Curr Opin Oncol. 2008;20:502-508.","DOI":"10.1097\/CCO.0b013e32830b61ac"},{"key":"key-10.17116\/terarkh201688762-71-5","doi-asserted-by":"crossref","unstructured":"Metzner B, Pott C, M\u00fcller TH, Gebauer W, Casper J, Kraemer D, Rosien B, Schumann-Binarsch S, Thole R, K\u00f6hne CH. Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation. Ann Oncol. 2013;24(6):1609-1615.","DOI":"10.1093\/annonc\/mds657"},{"key":"key-10.17116\/terarkh201688762-71-6","doi-asserted-by":"crossref","unstructured":"Sebban C, Brice P, Delarue R, Haioun C, Souleau B, Mounier N, Brousse N, Feugier P, Tilly H, Solal-C\u00e9ligny P, Coiffier B. Impact of rituximab and\/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study. J Clin Oncol. 2008;26 (21):3614-3620.","DOI":"10.1200\/JCO.2007.15.5358"},{"key":"key-10.17116\/terarkh201688762-71-7","doi-asserted-by":"crossref","unstructured":"Montoto S1, Corradini P, Dreyling M, Ghielmini M, Kimby E, L\u00f3pez-Guillermo A, Mackinnon S, Marcus RE, Salles G, Schouten HC, Sureda A, Dreger P. Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma:a consensus project of the EBMT Lymphoma Working Party. Haematologica. 2013 Jul; 98(7):1014-21.","DOI":"10.3324\/haematol.2013.084723"},{"key":"key-10.17116\/terarkh201688762-71-8","doi-asserted-by":"crossref","unstructured":"Rohatiner AZ, Nadler L, Davies AJ, Apostolidis J, Neuberg D, Matthews J, Gribben JG, Mauch PM, Lister TA, Freedman AS. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. J Clin Oncol. 2007;25(18):2554-2559.","DOI":"10.1200\/JCO.2006.09.8327"},{"key":"key-10.17116\/terarkh201688762-71-9","doi-asserted-by":"crossref","unstructured":"Kornacker M, Stumm J, Pott C, Dietrich S, S\u00fcssmilch S, Hensel M, Nickelsen M, Witzens-Harig M, Kneba M, Schmitz N, Ho AD, Dreger P. Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up. Ann Oncol. 2009;20:722-728.","DOI":"10.1093\/annonc\/mdn691"},{"key":"key-10.17116\/terarkh201688762-71-10","doi-asserted-by":"crossref","unstructured":"Hyun SY, Cheong JW, Kim SJ, Min YH, Yang DH, Ahn JS, Lee WS, Ryoo HM, Do YR, Lee HS, Lee JH, Oh SY, Suh C, Yhim HY, Kim JS. High-Dose Etoposide Plus Granulocyte Colony-Stimulating Factor as an Effective Chemomobilization Regimen for Autologous Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma Previously Treated with CHOP-based Chemotherapy: A Study from the Consortium for Improving Survival of Lymphoma. Biol Blood Marrow Transplant. 2014;20(1):73-79.","DOI":"10.1016\/j.bbmt.2013.10.012"},{"key":"key-10.17116\/terarkh201688762-71-11","doi-asserted-by":"crossref","unstructured":"Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L. Mobilization of tumor cells and hematopoetic progenitor cells into peripheral blood of patients with solid tumors. Blood. 1994;83(3):636-640.","DOI":"10.1182\/blood.V83.3.636.636"},{"key":"key-10.17116\/terarkh201688762-71-12","doi-asserted-by":"crossref","unstructured":"Espigado I, R\u00edos E, Mar\u00edn-Niebla A, Carmona M, Parody R, P\u00e9rez-Hurtado JM, M\u00e1rquez FJ, Urbano-Ispizua A. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy. Transplant Proc. 2008;40:3104-3105.","DOI":"10.1016\/j.transproceed.2008.08.092"},{"key":"key-10.17116\/terarkh201688762-71-13","doi-asserted-by":"crossref","unstructured":"Romero M, Bri\u00e8re J, de Bazelaire C, Leb\u0153uf C, Wang L, Ratajczak P, Sibon D, de Kerviler E, Thieblemont C, Janin A. Aflibercept-mediated early angiogenic changes in aggressive B-cell lymphoma. Cancer Chemother Pharmacol. 2011;68(5):1135-1143.","DOI":"10.1007\/s00280-011-1589-9"},{"key":"key-10.17116\/terarkh201688762-71-14","doi-asserted-by":"crossref","unstructured":"Baldo P, Rupolo M, Compagnoni A. Interferon-alpha for maintenance of follicular lymphoma. Cochrane Database Syst Rev. 2010;(1):CD004629.","DOI":"10.1002\/14651858.CD004629.pub2"},{"key":"key-10.17116\/terarkh201688762-71-15","doi-asserted-by":"crossref","unstructured":"Folkman J, D\u2019Amore PA. Blood vessel formation: what is its molecular basis? Cell. 1996;87:1153-1155.","DOI":"10.1016\/S0092-8674(00)81810-3"},{"key":"key-10.17116\/terarkh201688762-71-16","doi-asserted-by":"crossref","unstructured":"Ott G, Katzenberger T, Lohr A. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002;99(10):3806-3912.","DOI":"10.1182\/blood.V99.10.3806"},{"key":"key-10.17116\/terarkh201688762-71-17","doi-asserted-by":"crossref","unstructured":"Schneider M, Othman-Hassan K, Christ B, Wilting J. Lymphangioblasts in the avian wing bud. Dev Dyn. 1999;216:311-319.","DOI":"10.1002\/(SICI)1097-0177(199912)216:4\/5<311::AID-DVDY1>3.0.CO;2-M"},{"key":"key-10.17116\/terarkh201688762-71-18","doi-asserted-by":"crossref","unstructured":"Advani RH, Hong F, Horning SJ, Kahl BS, Manola J, Swinnen LJ, Habermann TM, Ganjoo K. Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial. Leuk Lymphoma. 2012;53(4):718-720.","DOI":"10.3109\/10428194.2011.623256"},{"key":"key-10.17116\/terarkh201688762-71-19","doi-asserted-by":"crossref","unstructured":"Aggarwal D, Srivastava G, Gupta R, Pant L, Krishan G, Singh S. Angiogenesis in Non-Hodgkin's Lymphoma: An Intercategory Comparison of Microvessel Density. ISRN Hematol. 2012;2012:943089.","DOI":"10.5402\/2012\/943089"},{"key":"key-10.17116\/terarkh201688762-71-20","doi-asserted-by":"crossref","unstructured":"Alduaij W, Illidge T. The future of anti-CD20 monoclonal antibodies: are we making progress? Blood. 2011;117(11):2993-3001.","DOI":"10.1182\/blood-2010-07-298356"},{"key":"key-10.17116\/terarkh201688762-71-21","doi-asserted-by":"crossref","unstructured":"Blystad AK, Delabie J, Kval\u00f8y S, Holte H, V\u00e5lerhaugen H, Ikonomou I, Kvalheim G. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy. Br J Haematol. 2004;125(5):605-612.","DOI":"10.1111\/j.1365-2141.2004.04951.x"},{"key":"key-10.17116\/terarkh201688762-71-22","unstructured":"T\u00f3thov\u00e1 E, Kafkov\u00e1 A, Guman T, Stecov\u00e1 N, Fricov\u00e1 M. Efficiency of in vivo purging with autologous stem cell transplantation and monoclonal antibody in B-cell lymphomas. Neoplasma. 2003;50(1):22-25."},{"key":"key-10.17116\/terarkh201688762-71-23","doi-asserted-by":"crossref","unstructured":"Andrade Campos M.MAndrade Campos MM, Montes Lim\u00f3n AE, Grasa JM, Lievano P, Baringo T, Giraldo P. RIT with Y90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution. J Oncol. 2012;2012:412742.","DOI":"10.1155\/2012\/412742"},{"key":"key-10.17116\/terarkh201688762-71-24","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12266"},{"key":"key-10.17116\/terarkh201688762-71-25","doi-asserted-by":"crossref","unstructured":"Gyan E, Foussard C, Bertrand P, Michenet P, Le Gouill S, Berthou C, Maisonneuve H, Delwail V, Gressin R, Quittet P, Vilque JP, Desablens B, Jaubert J,Ram\u00e9e JF, Arakelyan N, Thyss A, Molu\u00e7on-Chabrot C, Del\u00e9pine R, Milpied N, Colombat P, Deconinck E; Groupe Ouest-Est des Leuc\u00e9mies et des Autres Maladies du Sang (GOELAMS). High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years. Blood. 2009;113:995-1001.","DOI":"10.1182\/blood-2008-05-160200"},{"key":"key-10.17116\/terarkh201688762-71-26","doi-asserted-by":"crossref","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA,Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V; International Harmonization Project on Lymphoma. Revised Response Criteria for Malignant Lymphoma. J Clin Oncol. 2007;25:579-586.","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"key-10.17116\/terarkh201688762-71-27","unstructured":"Manual of Hematology of A Vorobyev. 3rd ed. Moscow: Novamed; 2003. (In Russ.)"},{"key":"key-10.17116\/terarkh201688762-71-28","doi-asserted-by":"crossref","unstructured":"Steffanoni S, Ghielmini M, Moccia A. Chemotherapy and treatment algorithms for follicular lymphoma: a look at all options. Expert Rev Anticancer Ther. 2015;28:1-13.","DOI":"10.1586\/14737140.2015.1092386"},{"key":"key-10.17116\/terarkh201688762-71-29","unstructured":"Nesterova E, Kravchenko S, Gemdzhian E, Magomedova A, Kaplanskaya I, Kovrigina A, Baryah E, Kremenetskaya A. The results of ten years\u2019 experience of treating patients with follicular lymphoma. Hematologiya i transfusiologiya. 2012;57(5):3-8. (In Russ.)"},{"key":"key-10.17116\/terarkh201688762-71-30","unstructured":"Collection of diagnostic and treatment protocols for diseases of the blood system. Ed. Savchenko V. Moscow: Practice; 2012. (In Russ.)"},{"key":"key-10.17116\/terarkh201688762-71-31","unstructured":"Nesterova E, Kravchenko S, Gemdzhian E, Osmanov E, Kovrigina A. Evaluation of tumor vascularization and microenvironment in follicular lymphoma. Terapevticheskii arkhiv. 2013;85(7):57-64. (In Russ.)"},{"key":"key-10.17116\/terarkh201688762-71-32","unstructured":"Nesterova E, Kovrigina A, Gemdzhyan E, Magomedova A, Baryakh E, Chernova N, Mar'in D, Gavrilina O, Lukina A, Vasil'eva K, Kravchenko S. Experience with the use of high-dose therapy with followed auto-SCT in follicular lymphoma in first-line therapy. Gematologiya i transfuziologiya. 2014;59(S1):54-55. (In Russ.)"},{"key":"key-10.17116\/terarkh201688762-71-33","doi-asserted-by":"crossref","unstructured":"Nesterova ES, Kravchenko SK, Kovrigina AM, Gemdzhian EG, Magomedova AU, Bariakh EA, Vorobyev VI, Iliushkina EA, Mariin DS, Chernova NG, Gavrilina OA, Lukina AE, Savchenko VG. Front-Line High Dose Therapy with Following Autologous Stem Cell Transplantation (ASCT) for Follicular Lymphoma Patients. Blood. 2014;124:5908. http:\/\/www.bloodjournal.org\/content\/124\/21\/5908","DOI":"10.1182\/blood.V124.21.5908.5908"},{"key":"key-10.17116\/terarkh201688762-71-34","unstructured":"Mangasarova Ia, Magomedova A, Kravchenko S, Shmakov R, Bariakh E, Vorob'ev V, Mar'in D, Skidan N, Gemdzhian E, Misiurin A, Kremenetskaia A, Vorob'ev A. Eight-year experience in treating aggressive mediastinal large B-cell lymphomas. Terapevticheskii arkhiv. 2013;85(7):50-56. (In Russ.)"},{"key":"key-10.17116\/terarkh201688762-71-35","doi-asserted-by":"crossref","unstructured":"Kuittinen T, Nousiainen T, Halonen P, Mahlam\u00e4ki E, Jantunen E. Prediction of mobilisation failure in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant. 2004;33(9):907-912.","DOI":"10.1038\/sj.bmt.1704466"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T05:01:30Z","timestamp":1600923690000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/terapevticheskij-arkhiv\/2016\/7\/downloads\/ru\/1004036602016071062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"alternative-id":["terarkh201688762-71"],"URL":"https:\/\/doi.org\/10.17116\/terarkh201688762-71","relation":{},"ISSN":["0040-3660"],"issn-type":[{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}